ATRA
Price
$13.39
Change
+$0.92 (+7.38%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
94.04M
Intraday BUY SELL Signals
MOLN
Price
$4.28
Change
+$0.15 (+3.63%)
Updated
Nov 13 closing price
Capitalization
153.49M
118 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ATRA vs MOLN

Header iconATRA vs MOLN Comparison
Open Charts ATRA vs MOLNBanner chart's image
Atara Biotherapeutics
Price$13.39
Change+$0.92 (+7.38%)
Volume$100
Capitalization94.04M
Molecular Partners AG
Price$4.28
Change+$0.15 (+3.63%)
Volume$1.25K
Capitalization153.49M
ATRA vs MOLN Comparison Chart in %
ATRA
Daily Signal:
Gain/Loss:
MOLN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ATRA vs. MOLN commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRA is a Hold and MOLN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ATRA: $12.47 vs. MOLN: $4.13)
Brand notoriety: ATRA and MOLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATRA: 139% vs. MOLN: 940%
Market capitalization -- ATRA: $94.04M vs. MOLN: $153.49M
ATRA [@Biotechnology] is valued at $94.04M. MOLN’s [@Biotechnology] market capitalization is $153.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRA’s FA Score shows that 1 FA rating(s) are green whileMOLN’s FA Score has 0 green FA rating(s).

  • ATRA’s FA Score: 1 green, 4 red.
  • MOLN’s FA Score: 0 green, 5 red.
According to our system of comparison, ATRA is a better buy in the long-term than MOLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRA’s TA Score shows that 4 TA indicator(s) are bullish while MOLN’s TA Score has 5 bullish TA indicator(s).

  • ATRA’s TA Score: 4 bullish, 6 bearish.
  • MOLN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MOLN is a better buy in the short-term than ATRA.

Price Growth

ATRA (@Biotechnology) experienced а +16.00% price change this week, while MOLN (@Biotechnology) price change was +2.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

MOLN is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MOLN($153M) has a higher market cap than ATRA($94M). ATRA YTD gains are higher at: -6.311 vs. MOLN (-13.016). ATRA has higher annual earnings (EBITDA): 14.3M vs. MOLN (-62.52M). MOLN has more cash in the bank: 114M vs. ATRA (22.3M). MOLN has less debt than ATRA: MOLN (1.84M) vs ATRA (17.7M). ATRA has higher revenues than MOLN: ATRA (189M) vs MOLN (681K).
ATRAMOLNATRA / MOLN
Capitalization94M153M61%
EBITDA14.3M-62.52M-23%
Gain YTD-6.311-13.01648%
P/E Ratio18.60N/A-
Revenue189M681K27,753%
Total Cash22.3M114M20%
Total Debt17.7M1.84M964%
FUNDAMENTALS RATINGS
ATRA: Fundamental Ratings
ATRA
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
33
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATRAMOLN
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 7 days ago
68%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ATRA
Daily Signal:
Gain/Loss:
MOLN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LISMF0.310.03
+9.06%
Lithium South Dev Corp.
SOHOF0.07N/A
N/A
Soho China, Ltd.
NGCRY39.00N/A
N/A
Nagacorp Ltd.
HANCF0.02N/A
N/A
HANSTONE GOLD CORP.
RKUNY6.70-0.09
-1.25%
Rakuten Group Inc.

ATRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRA has been loosely correlated with ABCZF. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRA jumps, then ABCZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRA
1D Price
Change %
ATRA100%
-0.72%
ABCZF - ATRA
53%
Loosely correlated
N/A
RAPT - ATRA
37%
Loosely correlated
-0.27%
PHAT - ATRA
36%
Loosely correlated
+1.81%
INVA - ATRA
33%
Poorly correlated
+1.74%
ABEO - ATRA
31%
Poorly correlated
+18.47%
More

MOLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MOLN has been loosely correlated with SNSE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MOLN jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MOLN
1D Price
Change %
MOLN100%
+2.48%
SNSE - MOLN
39%
Loosely correlated
+5.59%
SLDB - MOLN
36%
Loosely correlated
+4.64%
RCKT - MOLN
33%
Poorly correlated
+1.23%
ATRA - MOLN
31%
Poorly correlated
-0.72%
RAPT - MOLN
30%
Poorly correlated
-0.27%
More